Sign in →

Test ID BLOD0608 CA 125

Synonym

Ovarian Carcinoma Management, Cancer Antigen 125, Ovarian Cancer Tumor Marker, CA125 (Ovarian Cancer), OV Monitor

Specimen Type/Requirements

Sioux Falls 

Gold top (Serum w/gel) tube - Serum (preferred)

Red top (Serum w/out gel) tube - Serum

Light Green top (Lithium Heparin w/gel) tube - Plasma

 

Either serum or heparinized plasma may be used for testing.  However when monitoring a patient, use the same sample type to ensure consistent results.  

 

Multiple freeze/thaw cycles should be avoided.

 

Test is affected by gross hemolysis and gross lipemia.

 

This test should not be performed as an add-on test across specimen types.

 

Bismarck

Light Green top (Lithium Heparin w/gel) tube - Plasma

 

Avoid more than one freeze/thaw cycle.

 

Test may be affected by gross hemolysis, gross icterus and gross lipemia.

 

Specimen should be centrifuged and separated within 2 hours of collection.

Specimen Volume

Sioux Falls

 Preferred Volume     1.0 mL   
 Minimum Volume     0.3 mL   

Bismarck

 Preferred Volume     1.0 mL   
 Minimum Volume     0.5 mL   

Stability/Transport

Sioux Falls

 Room Temperature     8 hours     
 Refrigerated     7 days     
 Frozen     Greater than 7 days     Preferred for transport   

Bismarck

 Room Temperature     8 hours     
 Refrigerated     2 days     Preferred for transport   
 Frozen     6 months        

Performed Test Frequency

Monday through Sunday

Report Available

1 - 3 days

Additional Information

This test is used for management of Ovarian Carcinoma.  

Methodology

Sioux Falls

Chemiluminescence

Bismarck

Chemiluminescent One-Step Sandwich

Performing Lab

Sanford Laboratories Sioux Falls, Bismarck

CPT

86304

Coverage Limitations

This test has limited coverage – If applicable, please submit
Commercial Insurance Patient Waiver (Non-Medicare)